Ohcanbohtosat - Lisa Bodei

Aiddostahte ozu
  1. 1
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes

    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes Dahkki F. Edward Boas, Lisa Bodei, Constantinos T. Sofocleous

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics

    Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics Dahkki Kambiz Rahbar, Lisa Bodei, Michael J. Morris

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies

    Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies Dahkki Lisa Bodei, Valentina Ambrosini, Ken Herrmann, Irvin M. Modlin

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Somatostatin Receptor 2–Targeting Compounds

    Somatostatin Receptor 2–Targeting Compounds Dahkki Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom, Lisa Bodei

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?

    The Status of Neuroendocrine Tumor Imaging: From Darkness to Light? Dahkki Lisa Bodei, Anders Sundin, Mark Kidd, Vikas Prasad, Irvin M. Modlin

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Radiopharmaceutical therapy in cancer: clinical advances and challenges

    Radiopharmaceutical therapy in cancer: clinical advances and challenges Dahkki George Sgouros, Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Radiotheranostics in oncology: current challenges and emerging opportunities

    Radiotheranostics in oncology: current challenges and emerging opportunities Dahkki Lisa Bodei, Ken Herrmann, Heiko Schöder, Andrew M. Scott, Jason S. Lewis

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors Dahkki Irvin M. Modlin, Harry R. Aslanian, Lisa Bodei, Ignat Drozdov, Mark Kidd

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

    Neuroendocrine Tumor Biomarkers: Current Status and Perspectives Dahkki Irvin M. Modlin, Kjell Öberg, Andrew Taylor, Ignat Drozdov, Lisa Bodei, Mark Kidd

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Dahkki Serafino Ricci, Andrea Antonuzzo, Luca Galli, M Ferdeghini, Lisa Bodei, Cinzia Orlandini, Pierfranco Conté

    Almmustuhtton 2000
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy

    Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy Dahkki Jarosław B. Ćwikła, Lisa Bodei, Agnieszka Kolasińska-Ćwikła, A Sankowski, Irvin M. Modlin, Mark Kidd

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” Dahkki Boudewijn Brans, Lisa Bodei, Francesco Giammarile, O. Lindén, Markus Luster, Wim J.G. Oyen, Jan Tennvall

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Yttrium-labelled peptides for therapy of NET

    Yttrium-labelled peptides for therapy of NET Dahkki Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, Marco Chinol, Silvia M. Baio, Stefano Severi, Giovanni Paganelli

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

    Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors Dahkki Lisa Bodei, Marta Cremonesi, Mark Kidd, Chiara Maria Grana, Stefano Severi, Irvin M. Modlin, Giovanni Paganelli

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    The NETest

    The NETest Dahkki Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Targeted therapy in nuclear medicine—current status and future prospects

    Targeted therapy in nuclear medicine—current status and future prospects Dahkki Wim J.G. Oyen, Lisa Bodei, Francesco Giammarile, Helmut R. Maëcke, Jan Tennvall, Markus Luster, Boudewijn Brans

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

    The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors Dahkki Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Öberg, Irvin M. Modlin

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy Dahkki Lisa Bodei, Heiko Schöder, Richard P. Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin, Kjell Öberg, Irvin M. Modlin

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Neuroendocrine Neoplasms of the Small Bowel and Pancreas

    Neuroendocrine Neoplasms of the Small Bowel and Pancreas Dahkki Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Öberg, Irvin M. Modlin, Andrea Frilling

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors

    GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors Dahkki Wouter A. van der Zwan, Lisa Bodei, Jan Mueller‐Brand, Wouter W. de Herder, Larry K. Kvols, Dik J. Kwekkeboom

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: